Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel plus topotecan versus topotecan plus cisplatin in recurrent or persistent cervical carcinoma
2006-000349-20Phase 2Completed
- Sponsor
- Institut Frauengesundheit
- Start
- Jun 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in Cervical Cancer (CC) comparing Paclitaxel + topotecan with Cisplatin + topotecan (2 arms). Primary endpoints: Overall survival and Progression of disease. Started Jun 2006; status: completed.
02
Drugs
paclitaxeltopotecancisplatin
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on 2006-000349-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000349-20.